🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I clinical trial studies the side effects and the best dose of p...
Status
Completed
Location
Emory University
Start Date
2014-07-21
Trial ID
NCT02049541
Treatments Being Tested
Background: People with severe aplastic anemia (SAA) do not make enough re...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2016-12-19
Trial ID
NCT02979873
Treatments Being Tested
Minimal residual disease (MRD) monitoring is a key prognostic factor in ped...
Status
Recruiting
Location
Hôpital Armand Trousseau
Start Date
2026-04-24
Trial ID
NCT07483476
Treatments Being Tested
The Osteo-Medullary Biopsy (BOM) is a procedure carried out by means of a t...
Status
Completed
Location
Vannes hospital
Start Date
2023-06-19
Trial ID
NCT05178849
Treatments Being Tested
This phase II trial tests how well canakinumab works to prevent progression...
Status
Recruiting
Location
University of Miami
Start Date
2023-02-06
Trial ID
NCT05641831
It is a translational research study with mechanistical objectives and incl...
Status
Unknown
Location
Immunopathologie Clinique - Hôpital Saint Louis - AP HP
Start Date
2020-09-07
Trial ID
NCT04003220
Treatments Being Tested
The objective of this study is to evaluate the immune profile of plasma cel...
Status
Completed
Location
APHM
Start Date
2022-10-04
Trial ID
NCT05428163
Treatments Being Tested
The primary objective of this study, sponsored by Travera in Massachusetts,...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT04985357
A debilitating consequence of diabetes mellitus (DM) is neuropathy which gl...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02387749
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies, such as yttrium Y 90 ibritum...
Status
Completed
Location
Multiple Locations
Start Date
2000-05-16
Trial ID
NCT00562978
Treatments Being Tested